U

uniQure

Biotech firm developing curative gene therapies

Field Reimbursement Manager

Clinical Support & Patient AdministrationConfirmed live in the last 24 hours
Full-timeRemote in USA$168k - $218k

About the Job

Requirements

  • A bachelor's degree in business, healthcare, life sciences, or a related field is required.
  • Rare disease experience is required.
  • At least 8 years of experience in field reimbursement, market access, patient access, or related areas within the pharmaceutical, biotech, or healthcare industry is required.
  • Demonstrated success launching a high-value, high-innovation product such as gene therapy, cell therapy, or another high-innovation therapy within the last 3 years is required.
  • A deep understanding of United States reimbursement is required, including buy-and-bill and specialty pharmacy channels, medical and pharmacy benefit design, coding, prior authorization and appeals, and Medicare, Medicaid, and commercial payer processes.
  • Strong problem-solving and analytical skills are required, including the ability to navigate complex access scenarios and translate them into clear guidance for provider accounts.
  • Strong compliance orientation and sound judgment operating within legal and regulatory guidelines are required.
  • Ability to travel extensively within the assigned territory, with periodic travel to the home office as business needs dictate, is required.

Responsibilities

  • Serve as the field-based reimbursement expert within an assigned territory, educating treatment sites, billing and office staff, and referral sites on payer coverage, coding, and claims submission to support appropriate and timely payment.
  • Support the end-to-end reimbursement journey through benefit investigations, prior authorizations, appeals, and buy-and-bill versus specialty pharmacy considerations to help minimize barriers to patient access.
  • Educate accounts on relevant medical benefit design, applicable coding such as J-codes, CPT, and ICD, site-of-care considerations, and payer policy requirements specific to a one-time gene therapy.
  • Collaborate as needed with patient support Case Managers, Payor Account Directors, and treatment centers to resolve patient-specific and systemic access issues.
  • Support onboarding and launch readiness of new treatment sites and disease centers of excellence, coordinating with cross-functional partners to ensure sites are prepared to deliver treatment.
  • Identify, track, and communicate payer policy changes, reimbursement trends, and access barriers to internal stakeholders, including Market Access and field leadership.
  • Partner cross-functionally with Regional Account Management, Payor Account Directors, Patient Support Services, and Medical Affairs teams while maintaining compliance firewalls between reimbursement support and other field-based activities.
  • Deliver in-service education and training to office and billing staff on reimbursement processes and available patient support resources.
  • Represent the company professionally at assigned accounts and, as appropriate, at relevant conferences and stakeholder engagements.
  • Operate within legal, regulatory, and compliance guidelines without engaging in selling, pricing, or contract negotiations, or guaranteeing coverage or payment.

Desired Qualifications

  • Gene therapy experience is strongly preferred.
  • Experience supporting complex, high-innovation specialty or provider-administered products, and working with IDNs, hospital outpatient settings, surgical settings, and centers of excellence is preferred.
  • Excellent communication, presentation, and relationship-building skills, with demonstrated ability to work cross-functionally in a fast-paced, matrixed environment.

About the Company

uniQure

Biotech firm developing curative gene therapies

uniQure develops gene therapies aimed at curing severe genetic diseases. Its work centers on research and development, clinical trials, and partnerships to bring therapies to patients, including potential treatments for hemophilia B and Huntington's disease. The company’s products work by delivering genetic material to patients’ cells to correct or compensate for defective genes, with clinical programs progressing through trials to reach approval. Compared with peers, uniQure emphasizes curative gene therapy approaches and relies on licensing agreements and collaborations to fund development and scale its therapies. The ultimate goal is to provide approved, long‑lasting treatments that address unmet medical needs and improve patient outcomes.

Company size
201-500
Company stage
IPO
Headquarters
Amsterdam, Netherlands
Founded
1998

Recently Posted Jobs

Explore more opportunities at uniQure

See more jobs